DBV Technologies SA (DBVT)
9.75
+0.07
(+0.72%)
USD |
NASDAQ |
Oct 23, 16:00
9.74
-0.01
(-0.10%)
After-Hours: 20:00
DBV Technologies Enterprise Value : 364.13M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 364.13M |
| October 22, 2026 | 359.99M |
| October 21, 2026 | 356.44M |
| October 20, 2026 | 348.15M |
| October 19, 2026 | 317.97M |
| October 16, 2026 | 322.71M |
| October 15, 2026 | 326.26M |
| October 14, 2026 | 312.05M |
| October 13, 2026 | 321.52M |
| October 12, 2026 | 352.30M |
| October 09, 2026 | 367.09M |
| October 08, 2026 | 352.30M |
| October 07, 2026 | 365.32M |
| October 06, 2026 | 377.75M |
| October 05, 2026 | 404.97M |
| October 02, 2026 | 411.48M |
| October 01, 2026 | 450.54M |
| September 30, 2026 | 483.09M |
| September 29, 2026 | 470.66M |
| September 28, 2026 | 475.99M |
| September 25, 2026 | 471.25M |
| September 24, 2026 | 473.62M |
| September 23, 2026 | 507.36M |
| September 22, 2026 | 534.58M |
| September 21, 2026 | 503.21M |
| Date | Value |
|---|---|
| September 18, 2026 | 518.01M |
| September 17, 2026 | 527.48M |
| September 16, 2026 | 484.87M |
| September 15, 2026 | 483.09M |
| September 14, 2026 | 518.01M |
| September 11, 2026 | 488.42M |
| September 10, 2026 | 554.70M |
| September 09, 2026 | 582.52M |
| September 08, 2026 | 572.46M |
| September 04, 2026 | 584.29M |
| September 03, 2026 | 597.91M |
| September 02, 2026 | 592.58M |
| September 01, 2026 | 581.33M |
| August 31, 2026 | 605.01M |
| August 28, 2026 | 588.44M |
| August 27, 2026 | 639.93M |
| August 26, 2026 | 646.44M |
| August 25, 2026 | 673.07M |
| August 24, 2026 | 623.95M |
| August 21, 2026 | 648.21M |
| August 20, 2026 | 629.86M |
| August 19, 2026 | 661.82M |
| August 18, 2026 | 643.48M |
| August 17, 2026 | 655.31M |
| August 14, 2026 | 616.84M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Cellectis SA | 36.12M |
| Akari Therapeutics Plc | 7.336M |
| Bicycle Therapeutics Plc | -316.00M |
| EDAP TMS SA | 176.43M |
| Autolus Therapeutics Plc | 574.58M |
Enterprise Value Related Metrics
| EPS Diluted (Quarterly) | -0.5804 |
| Earnings Yield | -36.04% |
| Normalized Earnings Yield | -46.28 |